304 Vanucizumab reduces vessel permeability, perfusion and cellular density of tumor lesions in cancer patients as measured by DCE-MRI and DW-MRI. (September 2015) - Nayak, T.; Massard, C.; Martinez Garcia, M.; Le Tourneau, C.; Boni, V.; Garralda, E.; Taus, A.; Albanell, J.; Lahr, A.; Krieter, O.; Hidalgo, M.